Novozymes A/S is a global biotechnology company headquartered in Bagsværd, Denmark, specializing in the research, development and production of industrial enzymes and microorganisms. Since its spin-off from Novo Nordisk in 2000, Novozymes has become a leading supplier of biological solutions designed to enhance process efficiency, sustainability and resource utilization across a wide range of industries.
The company’s core offerings include enzyme formulations for applications in agriculture, bioenergy, food and beverages, household care, textile processing, pulp and paper, animal feed and waste treatment. By tailoring its biocatalysts to customer needs, Novozymes helps manufacturers lower energy and water consumption, reduce chemical usage and improve product quality. Key product lines include feed enzymes that support animal nutrition, cellulases for bioethanol production and amylases for starch conversion in food processing.
Novozymes serves customers in more than 100 countries, operating production facilities and application centers in Europe, North America, South America and Asia-Pacific. The company’s global footprint supports close collaboration with multinational corporations and local enterprises alike, enabling rapid adoption of enzyme technologies. Under the leadership of CEO Ester Baiget, who took the helm in 2021, Novozymes has continued to expand its market presence in emerging economies such as China, Brazil and India.
Research and development remain central to Novozymes’ strategy, with a workforce of scientists and engineers dedicated to discovering new biological solutions. The company invests heavily in sustainability initiatives, leveraging its expertise in fermentation and microbial engineering to develop climate-friendly processes. Through partnerships with industry, academia and public institutions, Novozymes aims to foster innovation that addresses global challenges such as food security, renewable energy and environmental protection.
AI Generated. May Contain Errors.
